4.7 Editorial Material

Complement inhibitor for therapy of CHAPLE

Journal

NATURE IMMUNOLOGY
Volume 22, Issue 2, Pages 106-108

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41590-020-00842-9

Keywords

-

Categories

Funding

  1. National Institute of Arthritis Musculoskeletal and Skin Disease grant [R01 AR073311]
  2. National Institutes of Health

Ask authors/readers for more resources

The study demonstrates successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.
A new study shows successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available